BREAKING NEWS

Russia to complete early-stage trials on 2nd COVID-19 vaccine on Sept. 30

Russia will complete early-stage trials on a second potential COVID-19 vaccine produced by the Vector Institute on Sept. 30, the RIA news agency cited Russia's consumer health safety watchdog as saying on Monday.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy